|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE
BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE
QUARTER ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000028626
<NAME> LIFECORE BIOMEDICAL, INC.
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 273,000
<SECURITIES> 0
<RECEIVABLES> 5,963,000
<ALLOWANCES> 193,000
<INVENTORY> 21,133,000
<CURRENT-ASSETS> 18,546,000
<PP&E> 42,462,000
<DEPRECIATION> 12,596,000
<TOTAL-ASSETS> 64,223,000
<CURRENT-LIABILITIES> 2,914,000
<BONDS> 6,449,000
0
0
<COMMON> 126,000
<OTHER-SE> 54,734,000
<TOTAL-LIABILITY-AND-EQUITY> 64,223,000
<SALES> 7,896,000
<TOTAL-REVENUES> 7,896,000
<CGS> 4,168,000
<TOTAL-COSTS> 8,295,000
<OTHER-EXPENSES> 54,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 216,000
<INCOME-PRETAX> (606,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (606,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (606,000)
<EPS-BASIC> (.05)
<EPS-DILUTED> (.05)
</TABLE>
|
|